在神经系统瘤中发芽
Petra Obexer1, Barbara Hausott2
1Department of Pediatrics II, Medical University of Innsbruck, 6020 Innsbruck, Austria.
International journal of molecular sciences
|January 10, 2026
概括
芽蛋白 (SPRY) 蛋白在神经系统瘤中具有多种作用. 在质母细胞瘤中,SPRY1和SPRY2充当瘤基因,而SPRY2则是神经母细胞瘤中的瘤抑制剂,突出了复杂的治疗潜力.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 神经科学是一个神经科学.
背景情况:
- 芽 (SPRY) 蛋白质 (SPRY1-4) 调节生长因子信号,在各种癌症中具有双重作用 (瘤基因/瘤抑制剂).
- 它们在神经系统瘤 (如质母细胞瘤 (GB) 和神经母细胞瘤 (NB)) 中的特定功能尚未完全理解.
- 之前的研究表明异型和恶性瘤特异性作用,SPRY1/2/4与其他癌症有关.
研究的目的:
- 审查关于SPRY1-4功能在质母细胞瘤和神经母细胞瘤中的文献.
- 分析SPRY1-4表达与质瘤,质母细胞瘤和神经母细胞瘤患者存活率的关联.
- 识别知识缺口并指导未来对神经系统瘤发生中的SPRY蛋白质的研究.
主要方法:
- 在质母细胞瘤和神经母细胞瘤中SPRY蛋白功能的文献综述.
- 对公共数据集的生物信息分析,将SPRY1-4表达与质瘤,质母细胞瘤和神经母细胞瘤患者的总生存率和无进展生存率相关联.
- 现有数据和生存分析结果的综合.
主要成果:
- 在质母细胞瘤中,SPRY1和SPRY2似乎作为瘤基因起作用;SPRY3和SPRY4的作用尚不清楚.
- 在神经母细胞瘤中,SPRY2充当瘤抑制剂.
- 低SPRY3表达与神经母细胞瘤患者的生存率增加相关,这表明潜在的瘤促进作用.
结论:
- SPRY蛋白在神经系统瘤中表现出复杂的,取决于环境的作用.
- 需要进一步研究神经母细胞瘤中SPRY1,SPRY3和SPRY4的功能.
- 了解SPRY蛋白的作用对于开发针对性治疗质母细胞瘤和神经母细胞瘤至关重要.
相关概念视频
Neurogenesis and Regeneration of Nervous Tissue
1.5K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.5K
Nervous Tissue: Glial Cells
6.5K
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
6.5K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K


